Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

VOLUNTARY ANNOUNCEMENT – RESEARCH UPDATES ON A PHASE I CLINICAL STUDY AND A PHASE I/II CLINICAL STUDY OF JSKN003 FOR PRESENTATION AT ESMO CONGRESS 2024 2024-09-15
INSIDE INFORMATION ANNOUNCEMENT – UPDATES IN RELATION TO A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED SQ NSCLC 2024-09-08
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 2024-09-05
Next Day Disclosure Return 2024-09-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 2024-09-03
Next Day Disclosure Return 2024-08-30
CONNECTED TRANSACTION ANNOUNCEMENT - RENEWAL OF THE LEASE AGREEMENT 2024-08-28
Next Day Disclosure Return 2024-08-27
VOLUNTARY ANNOUNCEMENT – ON-MARKET SHARE REPURCHASE 2024-08-15
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 2024-08-15